St. Jude Medical, Inc. (STJ) Stock Analysis
DELISTED 2017
What happened to St. Jude Medical, Inc. (STJ) stock?
St. Jude Medical, Inc. (STJ) no longer trades on public markets. It was delisted in January 2017. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
St. Jude Medical, Inc. (STJ) trades at $80.82. St. Jude Medical, Inc. specializes in developing medical devices and technologies for cardiovascular, atrial fibrillation, neurological, and chronic pain conditions. Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for STJ: STJ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates STJ against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
St. Jude Medical, Inc. (STJ) Healthcare & Pipeline Overview
St. Jude Medical, Inc., a key player in the medical device industry, focuses on cardiovascular, atrial fibrillation, neurological, and chronic pain solutions. With a strong emphasis on innovation and patient outcomes, the company maintains a significant presence through its diverse product portfolio and global reach, despite operating in a competitive market.
What Is the Investment Thesis for STJ?
St. Jude Medical presents a compelling investment case based on its established position in the growing medical device market. The company's diverse product portfolio, targeting cardiovascular, atrial fibrillation, neurological, and chronic pain conditions, provides a stable revenue base. A profit margin of 15.9% showcases the company's operational efficiency. Growth catalysts include continued innovation in medical device technology and expansion into emerging markets. However, investors may want to evaluate the potential risks associated with regulatory changes and intense competition within the medical device industry. The company's beta of 1.20 indicates a higher volatility compared to the market.
Based on FMP financials and quantitative analysis
STJ Key Highlights
Gross Margin of 68.5% indicates strong pricing power and efficient cost management.
- Profit Margin of 15.9% demonstrates effective operational performance.
- Focus on innovative medical devices for cardiovascular, atrial fibrillation, neurological, and chronic pain conditions.
- Global presence with sales in numerous countries, providing diversification.
- Commitment to research and development, driving future product innovation.
Who Are STJ's Competitors?
STJ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MDT Medtronic plc | $92.88 | -1.33% | $119B | 77 |
| BSX Boston Scientific Corporation | $52.01 | +3.05% | $77.3B | 80 |
| ABT Abbott Laboratories | $114.46 | +1.58% | $198B | 70 |
| SYK Stryker Corporation | $340.11 | +0.04% | $131B | 79 |
| EW Edwards Lifesciences Corporation | $92.28 | +1.43% | $53.1B | 93 |
| DXCM DexCom, Inc. | $89.92 | +0.04% | $33.9B | 93 |
| STE STERIS plc | $236.91 | +1.95% | $24.0B | 85 |
| ZBH Zimmer Biomet Holdings, Inc. | $100.72 | -0.02% | $19.5B | 78 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are STJ's Key Strengths?
Diverse product portfolio targeting multiple therapeutic areas.
- Strong brand reputation and established market presence.
- Commitment to research and development.
- Global distribution network.
What Are STJ's Weaknesses?
Reliance on regulatory approvals for new products.
- Exposure to product liability claims.
- Dependence on key suppliers.
- Competition from larger medical device companies.
What Could Drive STJ Stock Higher?
STJ catalyst: New product launches in the cardiovascular and neuromodulation segments are expected to drive revenue growth in the next 12-18 months.
- Continued expansion into emerging markets, particularly in Asia-Pacific, is anticipated to increase market share.
- Increasing adoption of minimally invasive procedures will drive demand for St. Jude Medical's products.
What Are the Key Risks for STJ?
Regulatory changes and delays in product approvals could impact the company's ability to bring new products to market.
- Product liability claims and recalls could result in significant financial losses and reputational damage.
- Intense competition from other medical device manufacturers could erode market share and pricing power.
What Are the Growth Opportunities for STJ?
- Growth opportunity 1: Expansion into emerging markets presents a significant growth opportunity for St. Jude Medical. The increasing healthcare expenditure and growing awareness of advanced medical treatments in countries like China and India create a large potential market for the company's products. By establishing strategic partnerships and tailoring products to local needs, St. Jude Medical can capitalize on this expanding market, with a projected market size of billions of dollars over the next decade.
- Growth opportunity 2: Innovation in cardiac rhythm management devices offers substantial growth prospects. As the prevalence of atrial fibrillation and other cardiac arrhythmias increases, the demand for advanced pacemakers, ICDs, and related technologies will continue to rise. St. Jude Medical's ongoing research and development efforts in this area can lead to the introduction of novel devices with improved efficacy and patient outcomes, capturing a larger share of the cardiac rhythm management market.
- Growth opportunity 3: Development of advanced neuromodulation therapies represents a key growth area. Neuromodulation devices, such as spinal cord stimulators and deep brain stimulators, are used to treat chronic pain, Parkinson's disease, and other neurological disorders. St. Jude Medical's expertise in this field, combined with the increasing adoption of neuromodulation therapies, positions the company to benefit from the growing market, estimated to reach several billion dollars in the coming years.
- Growth opportunity 4: Strategic acquisitions can drive growth by expanding St. Jude Medical's product portfolio and market presence. By acquiring companies with complementary technologies or established distribution networks, St. Jude Medical can accelerate its growth trajectory and enhance its competitive position. Identifying and integrating strategic acquisitions will be crucial for sustaining long-term growth and creating shareholder value.
- Growth opportunity 5: Focus on digital health solutions and remote monitoring technologies offers a new avenue for growth. The increasing adoption of telehealth and remote patient monitoring creates opportunities for St. Jude Medical to develop connected medical devices and digital health platforms that enable remote monitoring of patients with cardiovascular and neurological conditions. These solutions can improve patient outcomes, reduce healthcare costs, and generate recurring revenue streams for the company.
What Threats Does STJ Face?
- Intense competition from other medical device manufacturers.
- Pricing pressures from healthcare providers and payers.
- Changes in healthcare regulations.
- Technological obsolescence.
What Are STJ's Competitive Advantages?
- Strong intellectual property portfolio with patents protecting key technologies.
- Established brand reputation and long-standing relationships with healthcare providers.
- High barriers to entry due to stringent regulatory requirements and the need for specialized expertise.
- Extensive distribution network and global reach.
What Does STJ Do?
St. Jude Medical, Inc., founded with a vision to transform the treatment of cardiovascular diseases and other medical conditions, has evolved into a prominent global medical device manufacturer. The company develops, manufactures, and distributes a wide array of medical devices and technologies focused on cardiovascular, atrial fibrillation, neurological, and chronic pain management. Its product portfolio includes implantable cardiac devices such as pacemakers and implantable cardioverter-defibrillators (ICDs), as well as catheters, mapping and visualization systems, and structural heart devices. Over the years, St. Jude Medical expanded its reach through strategic acquisitions and organic growth, enhancing its technological capabilities and market presence. The company's commitment to innovation is reflected in its continuous investment in research and development, aimed at creating advanced medical solutions that improve patient outcomes and quality of life. St. Jude Medical's products are sold worldwide, serving hospitals, clinics, and physicians in various healthcare settings. The company's focus on addressing unmet medical needs and its dedication to advancing medical practices have solidified its position as a leader in the medical device industry.
What Products and Services Does STJ Offer?
- Develop and manufacture implantable cardiac devices such as pacemakers and ICDs.
- Produce catheters and mapping systems for diagnosing and treating cardiovascular conditions.
- Offer structural heart devices for valve repair and replacement.
- Provide neuromodulation devices for chronic pain management.
- Develop technologies for atrial fibrillation management.
- Distribute medical devices to hospitals, clinics, and physicians worldwide.
How Does STJ Make Money?
- Develop, manufacture, and sell medical devices for cardiovascular, atrial fibrillation, neurological, and chronic pain conditions.
- Generate revenue through direct sales to hospitals and clinics, as well as through distributors.
- Invest in research and development to create innovative medical solutions.
- Protect intellectual property through patents and trademarks.
What Industry Does STJ Operate In?
St. Jude Medical operates in the medical device industry, which is characterized by continuous innovation, stringent regulatory requirements, and intense competition. The market is driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. St. Jude Medical competes with other major medical device manufacturers, focusing on specific therapeutic areas such as cardiovascular and neurological devices. The industry is subject to regulatory oversight by agencies like the FDA, which impacts product development and market access.
Who Are STJ's Key Customers?
- Hospitals and clinics
- Cardiologists and electrophysiologists
- Neurologists and pain management specialists
- Patients with cardiovascular, atrial fibrillation, neurological, and chronic pain conditions
Company Profile
St. Jude Medical, Inc. operates in the Medical - Equipment & Services industry within the Healthcare sector. STJ has traded publicly since 1989.
Key Financial Metrics
Return on equity for St. Jude Medical, Inc. stands at 21.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.7%, showing how much profit it generates from its asset base. STJ trades at a trailing price-to-earnings ratio of 25.92, above the Healthcare sector average of ~23x. A current ratio of 1.32 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.9%, the inverse of the P/E and a quick read on earnings relative to price.
STJ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in St. Jude's future prospects, signaling potential undervaluation to those in the know.
- The community's generally upbeat mood around STJ indicates positive market perception and potential upward momentum.
- St. Jude's innovative medical device pipeline is viewed favorably, driving excitement about potential future revenue streams.
- Positive chatter suggests St. Jude is seen as a stable player in the healthcare sector, offering a relatively safe haven in uncertain times.
Bear Case
- Some community members express concerns about increasing regulatory scrutiny in the medical device industry, potentially impacting St. Jude.
- Negative sentiment surrounding competitor advancements could overshadow St. Jude's own innovations in the short term.
- Whispers of potential supply chain disruptions are causing unease, potentially affecting production and profitability.
- A segment of the community believes St. Jude's growth potential is limited compared to smaller, more agile competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
STJ Latest News
No recent news available for STJ.
St. Jude Medical, Inc. Healthcare Stock: Key Questions Answered
What happened to St. Jude Medical, Inc. (STJ) stock?
St. Jude Medical, Inc. (STJ) no longer trades on public markets. It was delisted in January 2017. The figures below are historical and are not a current quote.
Can I still buy STJ shares?
No. STJ stopped trading on public markets in January 2017, so the shares are not available through a broker. Anything you see quoted for STJ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before STJ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to St. Jude Medical, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does St. Jude Medical, Inc. do?
St. Jude Medical, Inc. is a global medical device manufacturer focused on developing and distributing innovative medical technologies and services. The company specializes in cardiovascular, atrial fibrillation, neurological, and chronic pain management solutions. Its product portfolio includes implantable cardiac devices, catheters, mapping systems, structural heart devices, and neuromodulation devices. St.
What do analysts say about STJ stock?
Analyst consensus on St. Jude Medical reflects a generally positive outlook, driven by the company's strong market position and growth prospects. Key valuation metrics, such as the P/E ratio of 25.92, suggest a premium valuation compared to some peers, reflecting investor confidence in the company's earnings potential.
What are the main risks for STJ?
St. Jude Medical faces several risks inherent to the medical device industry. Regulatory changes and delays in product approvals can significantly impact the company's ability to introduce new products and maintain market access. Product liability claims and recalls pose a threat to the company's financial stability and reputation.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending for STJ, which may provide additional insights.
- Financial data is based on available information as of 2026-03-17.